SBCM
Schwerin Boyle Capital Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Sell |
601,585
-88,900
| -13% | -$2.15M | 1.63% | 23 |
|
|
2025
Q1 | $17.5M | Sell |
690,485
-28,940
| -4% | -$733K | 1.8% | 19 |
|
|
2024
Q4 | $19.1M | Buy |
719,425
+3,700
| +0.5% | +$98.2K | 1.96% | 17 |
|
|
2024
Q3 | $20.7M | Sell |
715,725
-59,400
| -8% | -$1.72M | 2.17% | 15 |
|
|
2024
Q2 | $21.7M | Buy |
775,125
+58,850
| +8% | +$1.65M | 2.27% | 15 |
|
|
2024
Q1 | $19.9M | Buy |
716,275
+132,050
| +23% | +$3.66M | 1.98% | 17 |
|
|
2023
Q4 | $16.8M | Buy |
584,225
+12,000
| +2% | +$345K | 1.88% | 19 |
|
|
2023
Q3 | $19M | Sell |
572,225
-187,750
| -25% | -$6.23M | 2.23% | 16 |
|
|
2023
Q2 | $27.9M | Buy |
+759,975
| New | +$27.9M | 2.63% | 15 |
|